Avidity Partners Management’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-151,098
Closed -$104K 111
2023
Q1
$104K Sell
151,098
-409,202
-73% -$456K ﹤0.01% 82
2022
Q4
$504K Sell
560,300
-34,900
-6% -$50.9K 0.01% 83
2022
Q3
$851K Hold
595,200
0.02% 92
2022
Q2
$2.5M Hold
595,200
0.06% 70
2022
Q1
$3.99M Sell
595,200
-45,800
-7% -$381K 0.08% 77
2021
Q4
$7.88M Sell
641,000
-75,200
-10% -$1.61M 0.17% 65
2021
Q3
$16.4M Buy
+716,200
New +$18M 0.36% 60

Other funds holding REUN

Avidity Partners Management's REUN Position: Q2 2023 in Review

Avidity Partners Management sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q2 2023, closing a stake of 151,098 shares — an estimated $104K sold.

Avidity Partners Management first reported a position in REUN in Q3 2021 and held it in 7 quarters. The position peaked at $16.4M in Q3 2021. 21 funds tracked by Wall St. Rank hold REUN as of Q2 2023.

  • Avidity Partners Management reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q2 2023 after selling out during the quarter.
  • Avidity Partners Management sold 151,098 Reunion Neuroscience Inc. Common Shares shares in Q2 2023, an estimated $104K.
  • Avidity Partners Management first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 7 quarters.
  • Avidity Partners Management's Reunion Neuroscience Inc. Common Shares position peaked at $16.4M in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q2 2023.

Based on Avidity Partners Management's 13F filing for Q2 2023, filed 14 Aug 2023.